SPRYARS PHARMACEUTICALS INC

CUSIP: 82835W108

Guru Owners

$6.5M

Total Value Held

556,237

Total Shares

Investor	Fund	Shares	Value▼	% of Portfolio	Rpt Price	Period
Daniel Loeb	Third Point	556237	$6.5M	0.09%	$11.65	Q4 2025

Daniel Loeb

$6.5M

0.09%

📊 Fundamentals

Market Cap$810.8M

Forward P/E-10.8x

EPS (TTM)$-1.74

Revenue (TTM)$84.3M

Profit Margin-203.25%

Beta0.93

52-Week Range

$6.66

$18.90

Current: $8.16

Data from Yahoo Finance · refreshed every 4 hours

📊 Holdings Over Time

How superinvestor ownership has changed across quarters

Quarter-by-Quarter Activity

Q4 '251 owners · $6.5M

NEWDaniel Loeb$6.5M

SOLDStanley Druckenmiller

Q3 '241 owners · $7.8M

No changes

💰 DCF Calculator

DCF model · 10-yr forecast

Estimates depend entirely on your assumptions. Adjust the inputs below to explore scenarios.

⚠️ This company currently has negative free cash flow. The valuation assumes it will improve.

📊 Adjust the assumptions below to calculate an estimated fair value

Projection Period

Revenue Growth Rate

86%analyst est. 85.5%

0%100%

Growth Decay Rate

15%

0% (no decay)50% (fast decay)

Terminal Growth Rate

3.0%

0%5%

FCF Margin

5.0%current: -112.2%

1%50%

Discount Rate (WACC)

8.0%typical: 8% large caps · 10% growth

5%20%

Model: 10-year DCF · 3.0% terminal growth · Based on Yahoo Finance data